Impact and Curiosity Come to Life

The Phil and Penny Knight Campus for Accelerating Scientific Impact

calin plesa
Scientist boosts strength of genetic synthesis

Knight Campus assistant professor Calin Plesa is improving a tool used to synthesize genes to make the process simpler and less expensive.

Discover How

keat ghee ong
Energizing From Within

Keat Ghee Ong's startup is taking shape less than a year after the professor started at the University of Oregon's Knight Campus.

Learn More

adrian bubie
Adapting Cancer Research to COVID-19

Knight Campus graduate Adrian Bubie is helping to convert a newly developed tool for tracking cancer viruses to identify strains of the novel coronavirus.

Learn More

Connect with us

twitter iconlinkedin iconyoutube icon

knight campus lab view

The Knight Campus Strategic Plan

The plan lays out key priorities and areas of scientific focus, outlining the ideological foundation of the Knight Campus in detail.

View the Strategic Plan

Oregon's Combined Strengths
Leveraging the expertise of an entire state and region

In Oregon, we’re combining strengths with Oregon State University and Oregon Health & Science University to make a positive impact on society.

A Future of Collaborations

current affiliates
Faculty affiliation

UO faculty who want to be engaged with the Knight Campus' collaborative and interdisciplinary approach can apply for affiliation.

Explore the Affiliation Program

career acceleration

Career acceleration

The Knight Campus will provide cutting-edge professional development and training for students.

Find out More

Construction and traffic

Construction on the Phil and Penny Knight Campus for Accelerating Scientific Impact is ramping up. You can track progress on a webcam and read traffic updates.  

Construction Updates

Web Cam

webcam spring 2020

Knight Campus videos

Undergraduate Research at the Knight Campus

Knight Campus Undergraduate Scholar recipient, Emily Niebergall, is taking on her own independent research project with the help of a mentor to guide her every step of the way.

Imatinib as a Paradigm of Targeted Cancer Therapies

Dr. Brian Druker, director of OHSU's Knight Cancer Institute, discussed how he spearheaded the highly successful clinical trials of Imatinib for chronic myeloid leukemia.

Could Humans Someday Regrow Limbs?

Bob Guldberg explores his research on regenerative medicine and shares insights from his career translating new medical devices into improved patient care.



Calin Plesa is improving a cheaper way to synthesize genes that he helped create at UCLA

Adrian Bubie serves as a bioinformatician at the Icahn School of Medicine in New York

Work by a Knight Campus scientist could spur advances in AI and disease therapies

Balamurali K. Ambati also became the world's youngest doctor at age 17

A class on how to design experiments used coffee to help teach the scientific method

Kathleen Hall Jamieson, co-founder of FactCheck.org, will speak March 11 in the EMU

The conversation on Feb. 21 will examine recruitment, inclusion, culture in STEM programs

Applications are due Jan. 31 for those seeking associate and affiliate memberships

Marian Hettiaratchi aims to create a synthetic material that will enhance bone repair